• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自非癌性肝硬化组织的肝细胞以及来自癌性组织的肝细胞癌(HCC)细胞的DNA合成活性可以预测接受肝切除的HCC患者的生存期。

DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.

作者信息

Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Okamoto N, Ito Y, Tamai S, Iimori K, Sugimasa Y

机构信息

Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.

出版信息

Cancer. 1993 Jun 15;71(12):3859-63. doi: 10.1002/1097-0142(19930615)71:12<3859::aid-cncr2820711211>3.0.co;2-v.

DOI:10.1002/1097-0142(19930615)71:12<3859::aid-cncr2820711211>3.0.co;2-v
PMID:8389652
Abstract

BACKGROUND

There is a concept that a cancer often maintains some of the traits of the background tissue cells. Thus, the possibility exists that the DNA synthetic activity of the hepatocytes in cirrhotic tissue affects that of hepatocellular carcinoma (HCC) cells.

METHODS

DNA synthesis activity of hepatocytes from background cirrhotic tissue and HCC cells from cancerous tissue was studied in 30 patients with liver cirrhosis (LC) and HCC who had undergone hepatectomy; the study was done using the bromodeoxyuridine (BrdU)-anti-BrdU in vitro method. The correlation between the BrdU labeling index (LI) of hepatocytes from noncancerous cirrhotic tissue and that of HCC cells was studied. The relationship between both BrdU LI values and the survival after hepatectomy also was studied.

RESULTS

A significant correlation (r = 0.572; P < 0.001) was identified between the BrdU LI for HCC and that for noncancerous cirrhotic tissue. A significant correlation (r = -0.572; P < 0.05) was found between the BrdU LI of HCC cells and the survival after hepatectomy. A significant correlation (r = -0.678; P < 0.01) was observed between the BrdU LI of the noncancerous cirrhotic tissue and the survival.

CONCLUSIONS

It was concluded that a significant correlation existed between DNA synthesis of hepatocytes from the background cirrhotic tissue and that of HCC cells and that DNA synthesis activity of hepatocytes from noncancerous cirrhotic tissue and that of HCC cells from cancerous tissue could predict the survival of patients with HCC who had undergone hepatectomy.

摘要

背景

有一种观点认为,癌症通常会保留一些背景组织细胞的特征。因此,肝硬化组织中肝细胞的DNA合成活性有可能影响肝细胞癌(HCC)细胞的DNA合成活性。

方法

对30例接受肝切除术的肝硬化(LC)和HCC患者,采用体外溴脱氧尿苷(BrdU)-抗BrdU法,研究背景肝硬化组织中肝细胞和癌组织中HCC细胞的DNA合成活性。研究了非癌性肝硬化组织中肝细胞的BrdU标记指数(LI)与HCC细胞的BrdU标记指数之间的相关性。还研究了两个BrdU LI值与肝切除术后生存率之间的关系。

结果

HCC的BrdU LI与非癌性肝硬化组织的BrdU LI之间存在显著相关性(r = 0.572;P < 0.001)。HCC细胞的BrdU LI与肝切除术后生存率之间存在显著相关性(r = -0.572;P < 0.05)。非癌性肝硬化组织的BrdU LI与生存率之间存在显著相关性(r = -0.678;P < 0.01)。

结论

得出结论,背景肝硬化组织中肝细胞的DNA合成与HCC细胞的DNA合成之间存在显著相关性,非癌性肝硬化组织中肝细胞的DNA合成活性和癌组织中HCC细胞的DNA合成活性可预测接受肝切除术的HCC患者的生存率。

相似文献

1
DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.来自非癌性肝硬化组织的肝细胞以及来自癌性组织的肝细胞癌(HCC)细胞的DNA合成活性可以预测接受肝切除的HCC患者的生存期。
Cancer. 1993 Jun 15;71(12):3859-63. doi: 10.1002/1097-0142(19930615)71:12<3859::aid-cncr2820711211>3.0.co;2-v.
2
Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.肝细胞DNA合成活性增加在肝硬化合并肝细胞癌肝切除患者残余肝多中心肝癌发生中的作用
Jpn J Cancer Res. 1994 Oct;85(10):1040-4. doi: 10.1111/j.1349-7006.1994.tb02903.x.
3
Difference in the in vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma.伴有和不伴有肝细胞癌的肝硬化患者之间溴脱氧尿苷体外摄取的差异。
Cancer. 1989 Jul 1;64(1):104-9. doi: 10.1002/1097-0142(19890701)64:1<104::aid-cncr2820640119>3.0.co;2-5.
4
The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men.肝硬化患者中肝细胞癌发病率男性占优势可能取决于男性肝硬化组织中较高的DNA合成活性。
Cancer. 1993 Jul 15;72(2):369-74. doi: 10.1002/1097-0142(19930715)72:2<369::aid-cncr2820720210>3.0.co;2-5.
5
Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.抗丙型肝炎病毒阳性肝硬化患者肝细胞增殖在肝细胞癌发生中的意义。
Cancer. 1994 Feb 15;73(4):1149-54. doi: 10.1002/1097-0142(19940215)73:4<1149::aid-cncr2820730405>3.0.co;2-9.
6
Increased DNA synthetic potency of hepatocytes in cirrhotic patients may indicate a super-high risk for hepatocellular carcinoma.肝硬化患者肝细胞的DNA合成能力增强可能表明其患肝细胞癌的风险极高。
Jpn J Med. 1990 Jul-Aug;29(4):373-8. doi: 10.2169/internalmedicine1962.29.373.
7
Evidence of sex difference in DNA synthesis in hepatocellular carcinoma.肝细胞癌中DNA合成存在性别差异的证据。
Jpn J Cancer Res. 1991 Aug;82(8):922-6. doi: 10.1111/j.1349-7006.1991.tb01922.x.
8
Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.对肝细胞癌患者肝硬化肝细胞进行流式细胞术DNA分析可提供一种新的预后因素。
Cancer. 1996 Sep 15;78(6):1195-202. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.0.CO;2-9.
9
In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior.人肝细胞癌对溴脱氧尿苷的体外摄取及其与组织病理学发现和生物学行为的关系。
Cancer. 1991 Oct 15;68(8):1789-94. doi: 10.1002/1097-0142(19911015)68:8<1789::aid-cncr2820680823>3.0.co;2-a.
10
Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.慢性乙型肝炎伴或不伴肝硬化患者肝切除术后肝细胞癌无病生存期的比较。
J Med Assoc Thai. 2015 Apr;98(4):334-42.

引用本文的文献

1
Assessment of Primary Human Liver Cancer Cells by Artificial Intelligence-Assisted Raman Spectroscopy.人工智能辅助拉曼光谱评估原发性肝癌细胞。
Cells. 2023 Nov 17;12(22):2645. doi: 10.3390/cells12222645.
2
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.溴脱氧尿苷:生物学与医学中的诊断工具,第二部分:肿瘤学、化疗与致癌作用
Histochem J. 1995 Dec;27(12):923-64.